A human immunodeficiency syndrome caused by mutations in CARMIL2
CARMIL2 (Rltpr) is involved in T-cell function. Here, the authors identify human CARMIL2-deficiency as an autosomal recessive primary immunodeficiency disorder characterized by EBV+smooth muscle tumours, CD28 co-signalling deficiency and impaired cytoskeletal dynamics.
Main Authors: | T. Schober, T. Magg, M. Laschinger, M. Rohlfs, N. D. Linhares, J. Puchalka, T. Weisser, K. Fehlner, J. Mautner, C. Walz, K. Hussein, G. Jaeger, B. Kammer, I. Schmid, M. Bahia, S. D. Pena, U. Behrends, B. H. Belohradsky, C. Klein, F. Hauck |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms14209 |
Similar Items
-
Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency
by: Anas M. Alazami, et al.
Published: (2018-02-01) -
A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors
by: Jennifer R. Yonkof, et al.
Published: (2020-06-01) -
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers
by: Giuseppe Marangi, et al.
Published: (2020-01-01) -
Epstein–Barr Virus+ Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders
by: Thomas Magg, et al.
Published: (2018-02-01) -
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease
by: Luca Bosa, et al.
Published: (2021-03-01)